Tetrahydrocannabivarin (thc) for use in the protection of pancreatic islet cells
AssigneeGW Pharma Limited
InventorsMichael Cawthorne, Colin Stott, Stephen Wright
Life of this patent
Estimating the term…
Abstract
The present invention relates to the phytocannabinoid tetrahydrocannabivarin (THCV) for use in the protection of pancreatic islet cells. Preferably the pancreatic islet cells to be protected are beta cells. More preferably the protection of the pancreatic islet cells maintains insulin production at levels which are able to substantially control or improve control of blood glucose levels in a patient.
Claims17
A method for treating diabetes or pre-diabetes comprising administering to a patient requiring protection of pancreatic islet cells a therapeutically effective amount of phytocannabinoid tetrahydrocannabivarin (THCV).
Dependencies are inferred from the claim text.